Slovenia not changing AstraZeneca jab strategy for now
Ljubljana, 8 April - Slovenia will not change its Covid-19 vaccination strategy for the time being, the head of the national immunisation advisory body has said after the European Medicines Agency (EMA) announced that unusual blood clots should be listed as a very rare side effect of the AstraZeneca vaccine.
The rest of this news item is available to subscribers.
The news item consists of 1.990 characters (without spaces) or 377 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.